Funding for this research was provided by:
F. Hoffmann-La Roche
Danish Agency for Science and Higher Education
Danish Research Foundation
Received: 6 May 2021
Accepted: 11 July 2021
First Online: 15 July 2021
: All patients provided written informed consent and the cohort was approved by the Regional Ethics committee (H-16001790) and the Danish Data Protection Agency (HGH-2016–017). The PFBIO study was registered at ExternalRef removed (NCT02772549) on April 29, 2016.
: Not applicable.
: HJ, PF,, MAK, DJL and JMBS are employed by Nordic Bioscience, Biomarkers and Research. MAK, DJL and JMBS are shareholders in Nordic Bioscience. None of the authors from Nordic Bioscience received any kind of financial benefits or other bonuses for the work described in this manuscript. NH reports grants from Roche a/s, Skibsreder Per Henriksen, R. og Hustrus Fond, and from Aase og Ejnar Danielsens Fond, during the conduct of the study. TSP reports grants from Boehringer Ingelheim, during the conduct of the study; personal fees from Roche A/S, personal fees from Boehringer Ingelheim, outside the submitted work. EB reports grants, personal fees and other from Roche, grants, personal fees and other from Boehringer Ingelheim, outside the submitted work.